# Kiora Pharmaceuticals Inc: Form 8-K, filed Sep 14, 2020

- Company: [Kiora Pharmaceuticals Inc](/companies/kprx.md) (CIK 1372514)
- Form: 8-K
- Filed: 2020-09-14
- Accepted by EDGAR: Sep 14, 2020, 06:50 ET
- Period: 2020-09-14
- Accession: 0001104659-20-104579
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1372514/000110465920104579/tm2030710d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1372514/000110465920104579/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1372514/000110465920104579/tm2030710d1_8k.htm

Filed Sep 14, 2020.
Source: SEC EDGAR, the filing index for accession 0001104659-20-104579. Last ingested by Listed: Nov 12, 2026, 17:43 ET. No prices; not investment advice.
